Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 5, 2015, Pages e125-e127

  Prontera, Concetta ^b   Masotti, Silvia ^a   Franzini, Maria ^a   Emdin, Michele ^b   Passino, Claudio ^b   Zucchelli, Gian Carlo ^c   Clerico, Aldo ^a  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

^b CNR   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

brain natriuretic peptide (BNP); immunoassay; natriuretic peptides; point of care testing (POCT) methods

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AUTOMATION; CAPILLARY BLOOD; HEART FAILURE; HUMAN; IMMUNOASSAY; IMMUNOASSAY ANALYZER; INTERMETHOD COMPARISON; LETTER; POINT OF CARE TESTING; PRIORITY JOURNAL; REPRODUCIBILITY; TEST STRIP; VENOUS BLOOD; BLOOD; BLOOD ANALYSIS; CAPILLARY; COMPARATIVE STUDY; PROCEDURES; VEIN;

AUTOMATION; BLOOD CHEMICAL ANALYSIS; CAPILLARIES; HUMANS; NATRIURETIC PEPTIDE, BRAIN; POINT-OF-CARE TESTING; VEINS;

EID: 84928003888     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0873     Document Type: Letter

References (8)

1. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, et al.; American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;62:e147-239.
2. Emdin E, Clerico A, Clemenza F, Galvani M, Latini R, Masson S, et al. Consensus document. Recommendations for the clinical use of cardiac natriuretic peptides. J Cardiovasc Med (Ital Heart J) 2005;6:430-46.
3. Maisel A, Barnard D, Jaski B, Frivold G, Marais J, Azer M, et al. Primary results of the HABIT Trial (Heart failure assessment with BNP in the home). J Am Coll Cardiol 2013;61:1726-35.
4. Heart Check BNP Test Strip product insert. 00377 SPEC-0492 Rev. 1 2011Alere Technologies Ltd., Stirling, Scotland.
5. Prontera C, Storti S, Emdin M, Passino C, Zyw L, Zucchelli GC, et al. Comparison of a fully automated immunoassay with a point-of-care testing method for B-type natriuretic peptide. Clin Chem 2005;51:1274-6.
6. Prontera C, Zaninotto M, Giovannini S, Zucchelli GC, Pilo A, Sciacovelli L, et al. Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmoCheck study. Clin Chem Lab Med 2009;47:762-8.
7. Clerico A, Zaninotto M, Prontera C, Giovannini S, Ndreu R, Franzini M, et al. Study Group on Cardiovascular Risk Biomarkers of the Italian Society of Clinical Biochemistry. State of the art of BNP and NT-proBNP immunoassays: the CardioOrmoCheck study. Clin Chim Acta 2012;414:112-9.
8. Franzini M, Masotti S, Prontera C, Ripoli A, Passino C, Giovannini S, et al. Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials. Clin Chim Acta 2013;424:287-91.